We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Diligence Milestone definition

Diligence Milestone has the meaning set forth in Section 3.1(b).
Diligence Milestone has the meaning set forth in Section 4.4 (Development Diligence Obligations).
Diligence Milestone shall have the meaning set forth in Section 3.5 of this Agreement.

Examples of Diligence Milestone in a sentence

  • Upon payment of each Extension Fee with respect to any of the Diligence Milestones, an additional year will be added to the time for completion of such Diligence Milestone and all other as yet unmet Diligence Milestones.

  • A material breach shall include but not be limited to the following: (i) failure to deliver to APL any payment at the time such payment is due under this Agreement, (ii) failure to meet or achieve a Diligence Milestone by the applicable Achievement Date (and any permitted extension), (iii) failure to possess and maintain required insurance coverage, and (iv) delivery of a false report to APL.

  • Licensee shall provide COH with prompt notice of meeting each of the foregoing Therapeutic Diligence Milestone which notice shall be accompanied by reasonable documentary evidence of the satisfaction of the applicable Therapeutic Diligence Milestone.

  • Finally, it is important to recognize the normativity of the conceptual debate.

  • Upon agreement of the Parties with respect to the deadlines for such Second Extended Milestones, Licensee shall make a non-creditable payment of one-half of the Milestone Fee of the Milestone Event corresponding to said Diligence Milestone Event.


More Definitions of Diligence Milestone

Diligence Milestone. On or before the six month anniversary of the Effective Date, LICENSEE will have completed assumed lease to prior AGT facilities or otherwise acquired other facilities to continue development and commercialization of the Licensed Technology.
Diligence Milestone means, with respect to any table for a Licensed Product in Exhibit D, each milestone event described in the “Milestone” column of any row of such table.
Diligence Milestone has the meaning set forth in Section 2.5.4.
Diligence Milestone means each of the outcomes referenced under “Milestone” below relating to the Development Program for the Compound, along with the deadline for achieving the particular outcome referenced under “Deadline” in the right hand column opposite that outcome. The Parties acknowledge and agree that the Diligence Milestones set forth below are specified herein solely for purposes of conclusively establishing that if Avalon should fail to achieve a Diligence Milestone by the specified Deadline date, Avalon has not satisfied the requirements of this Section 3.6. However, completion of a Diligence Milestone on or about the corresponding deadline shall not be considered presumptive evidence that Avalon shall have satisfied its general development obligations as set forth in the first paragraph of this Section 3.6. Milestone Deadline IND Filed with FDA * (subject to extension under Section 4.2) Initiate Phase Ib Clinical Trial Within * after the FDA Accepts the IND Initiate a Phase II Clinical Trial No later than * after the LPO of the Phase Ib Clinical Trial Initiate Pivotal Registration Study No later than * after Phase II FDA Meeting If the first Pivotal Registration Study trial is unsuccessful, the commencement of a follow on Pivotal Registration Study No later than * after the LPO of the unsuccessful Pivotal Registration Study File NDA in a Major Market country No later than * after LPO of the successful Pivotal Registration Study (or Studies) for the lead Indication File application for Regulatory Approval in all Major Market countries (in which Avalon has retained rights to the Compound) except Japan No later than * after LPO of the Pivotal Registration Study (or Studies) leading to the filing of an NDA in a Major Market Country for the lead Indication File application for Regulatory Approval in Japan (assuming that Avalon has retained rights to the Compound in Japan) No later than * after LPO in the Pivotal Registration Study (or Studies) for the lead Indication * The asterisk denotes the confidential portions of this document that have been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. For example, a Diligence Milestone would be achieved if an IND is filed with the FDA on or before * (or, if such date is extended pursuant to Section 4.2). It would not be achieved if an IND is not filed with the FDA on or before * (or, if such date is extended pursuant to Section 4.2). Ava...
Diligence Milestone shall have the meaning provided in Section 3.2.
Diligence Milestone. [EXAMPLES: “On or before the anniversary of the Effective Date, LICENSEE shall ” OR “During the -month/year period beginning on the anniversary of the Effective Date and during each succeeding -month/year period, LICENSEE shall ”]
Diligence Milestone means each of the milestones set forth in Section 3.2.